Glimblist M1 Tablet

Glimepiride 1 mg & Metformin 500 mg for Type 2 Diabetes Management

Glimblist M1 Tablet is a combination oral anti-diabetic formulation used to support blood sugar management in individuals with type 2 diabetes. It combines two complementary mechanisms of action in a single tablet.

Key Benefits

• ✓ Helps support blood sugar management in type 2 diabetes
• ✓ Combines two complementary anti-diabetic mechanisms in one tablet
• ✓ Convenient combination formulation as part of an overall treatment plan
• ✓ Suitable for use alongside diet and lifestyle changes as advised by your doctor

Composition

Each tablet contains:

• Glimepiride – 1 mg
• Metformin – 500 mg

Who Can Benefit?

Glimblist M1 Tablet may be suitable for individuals who have been prescribed treatment for:

• Type 2 diabetes requiring combination oral therapy
• Blood sugar management alongside diet and lifestyle changes

How to Use

Use Glimblist M1 Tablet only in the dose and frequency prescribed by your doctor.

Take the tablet with a meal, as directed, to help reduce the risk of low blood sugar.

Do not skip meals after taking this medicine.

Do not stop or change the dose without consulting your doctor.

Storage Instructions

Store in a cool, dry place away from direct sunlight.

Keep the strip or container tightly closed when not in use.

Keep out of reach of children.

Safety Information

Use Glimblist M1 Tablet only under the supervision of a qualified healthcare professional.

Monitor blood sugar levels as advised by your doctor.

Inform your doctor about other medicines you are taking.

Be aware of the signs of low blood sugar (dizziness, sweating, shakiness) and how to manage them, as advised by your doctor.

Seek medical advice if symptoms of high or low blood sugar occur.

Why Choose Glimblist M1 Tablet?

Glimblist M1 Tablet combines Glimepiride and Metformin in a single, clearly defined formulation for type 2 diabetes management. Its transparent composition and clear usage guidance support safe, doctor-directed use.